Armotraz 1 mg (Anastrozole 1mg)

Armotraz 1mg Tablet falls under a category of drugs known as aromatase inhibitor. It is used to treat breast cancer in post-menopausal women. It functions by lowering the estradiol concentrations in the blood which slows down the tumor growth and size.

On using Armotraz 1mg Tablet you may experience side effects such as muscle pain, breast pain, diarrhoea, constipation, cough, dizziness, flu-like symptoms, stomach pain, vomiting, difficulty with sleeping, weakness, rapid weight gain, reduced appetite, hives, headache, skin rash, numbness, irregular heartbeat, clouded thoughts, fever, chills, skin ulcers and swelling. Notify your doctor promptly should any of the allergic reaction show and worsen over time.

Before using this medication tell your doctor if; you are allergic to any ingredient contained with Armotraz 1mg Tablet, you have any allergy to foods, medicines or substances, you are yet to go through menopause, you are taking any other medications especially those containing estrogen, you have history of liver problems/ heart diseases/ osteoporosis/ high cholesterol.

The dosage should be prescribed by the doctor based on your overall medical history, age and current condition. The usual dose in adults diagnosed with breast cancer is about 1 mg orally once per day.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Breast Cancer

Headache

Hot Flushes

Nausea

Skin Rash

Musculoskeletal Bone

Muscle Or Joint Pain

Osteoporosis

Weakness

Are there any missed dose instructions?

If you miss a dose of Anastrozole, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.\n

This medication works by lowering the level of estrogen in menopausal women, thereby, reducing the risk of breast cancer. It judiciously blocks aromatase. Aromatase allows estrogen to circulate by converting adrenally-formulated androstenedione to estrone. Therefore, its prevention decreases the chances of tumour development.